Stablepoint Partners’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,192
Closed -$51K 269
2025
Q4
$51K Sell
10,192
-1,778
-15% -$9.26K 0.01% 244
2025
Q3
$60.7K Sell
11,970
-7,361
-38% -$32.4K 0.01% 248
2025
Q2
$83.3K Sell
19,331
-1,255
-6% -$6.2K 0.01% 248
2025
Q1
$124K Sell
20,586
-5,100
-20% -$25.8K 0.02% 241
2024
Q4
$101K Sell
25,686
-19,827
-44% -$88.8K 0.02% 239
2024
Q3
$266K Sell
45,513
-3,419
-7% -$16.9K 0.05% 218
2024
Q2
$246K Sell
48,932
-308,434
-86% -$1.48M 0.05% 223
2024
Q1
$1.68M Buy
357,366
+20,201
+6% +$77.3K 0.34% 92
2023
Q4
$1.66M Buy
+337,165
New +$1.65M 0.42% 69

Other funds holding MPT

Stablepoint Partners's MPT Position: Q1 2026 in Review

Stablepoint Partners sold out of Medical Properties Trust (MPT) in Q1 2026, closing a stake of 10,192 shares — an estimated $51K sold.

Stablepoint Partners first reported a position in MPT in Q4 2023 and held it in 9 quarters. The position peaked at $1.68M in Q1 2024. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Stablepoint Partners reported no remaining Medical Properties Trust position as of Q1 2026 after selling out during the quarter.
  • Stablepoint Partners sold 10,192 Medical Properties Trust shares in Q1 2026, an estimated $51K.
  • Stablepoint Partners first reported a position in Medical Properties Trust in Q4 2023 and held it in 9 quarters.
  • Stablepoint Partners's Medical Properties Trust position peaked at $1.68M in Q1 2024.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Stablepoint Partners's 13F filing for Q1 2026, filed 30 Apr 2026.